Home Equities Score Vaxart, Inc. (VXRT) Stock Prices Skyrocket Following Announcement of T-cell Webinar

Vaxart, Inc. (VXRT) Stock Prices Skyrocket Following Announcement of T-cell Webinar

Vaxart, Inc. (VXRT) stock prices were up a staggering 37.46% as of market close on April 27th, 2021, bringing the price per share up to USD$8.33.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Novel COVID-19 Tablet

With the world hurtling towards COVID-19 solutions for the pandemic, VXRT is setting itself apart from its competitors with a drug, VXA-CoV2-1, that comes in tablet form rather than via injections. This circumvents the issue of the transportation of typical covid injections being a costly endeavor. Furthermore, it could facilitate the acceleration of universal immunizations because the administration of a tablet does not require specialized healthcare professionals in the way injections do.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Read More

Competitive Advantage of VXA-CoV2-1

Another massive differentiator of VXRT’s VXA-CoV2-1 is that it has the potential to be effective against the various strains of the COVID-19 virus that are emerging and are proving to be resistant to typical injection-based vaccinations. With the drug targeting nucleoprotein (N) as well as spike proteins (S), a significant T-cell response has been observed as a target of the N protein. This is significant because a potent T-cell response has the potential to offer protection against even more severe covid symptoms.

Additional Developments

So far, the drug has met its primary endpoint as well as all of its secondary endpoints in the first phase of its trial. VXRT has been collaborating with Kindred Biosciences for the manufacturing of various COVID-19 vaccine candidates, including VXA-CoV2-1. Under a recently expanded agreement, the plant located in California will see the scaling of clinical trial material into mid-size bioreactors. The agreement will also see the single-use bioreactors in the Kansas plant being used for manufacturing at a 2000L scale.

Agreement with Attwill

An agreement has also been entered with Attwill Vascular Technologies that will facilitate the processing and lyophilizing of specific compounds, as well as the tableting of the lyophilized compounds for use in VXA-CoV2-1. To capitalize on recent developments, the company has increased its workforce to 49 full-time employees, with hiring have been primarily conducted in R&D, clinical, regulatory manufacturing, and financial areas.

Promising Liquidity Position

December 31st, 2020 saw the company report cash and cash equivalents of USD$126.9 million, a monumental increase from the USD$13.5 million reported as of December 31st 2019. The healthy liquidity position is attributable to the USD$97 million netted from the company’s USD$100 million at-the-market facility from June 2020; the exercising of warrants, which netted VXRT USD$26 million; USD$9.2 having been raised from a registered direct offering in March 2020; and USD$4.9 million from VXRT’s USD$250 million at-the-market facility from October 2020.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Future Outlook for VXRT

The success of Phase 1 of VXA-CoV2-1’s clinical trial has boosted investor confidence, who continue to back the company as it gears up for Phase 2. With such promising results, partnerships to facilitate the hopeful commercial production of the drug, and a solid liquidity position, the company is poised to leverage its resources to come out ahead in the COVID-19 vaccine race. Both current and prospective shareholders are hopeful for the future of the company, as evidence by recent surges in VXRT stock prices.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

IT Tech Packaging Inc. (ITP) stock gains during pre-market. Here’s what’s happening?

IT Tech Packaging Inc. (NASDAQ: ITP) stock gained by 7.53% at last close while the ITP stock price rises by 2.04% in the pre-market...

Why did The9 Limited (NCTY) stock turnaround in the after-hours on Friday?

The9 Limited (NCTY) shares gained 6.87% in after-hours on Friday, July 30, 2021, and closed the weekly trading at $11.98 per share. in the...

Energous Corporation Inc. (WATT) stock declines during after-market. Here’s to know why?

Energous Corporation Inc. (WATT) stock gained by 7.05% at last close whereas the WATT stock price plunged by 7.82% in the after-hours trading session....

AMAZON Inc. (AMZN) stock fell during after-market. Here’s the update

Amazon Inc. (NASDAQ: AMZN) stock plunged by 0.84% at last close however moving ahead the AMZAN share price also declines by 7.44% in the...

Cocrystal Pharma Inc. (COCP) stock soars during current market. Here’s what you should know

Cocrystal Pharma Inc. (NASDAQ: COCP) stock gains by 17.44% in the current market trading session. Cocrystal Pharma, Inc. is a clinical-stage biotechnology firm focused...

Best Inc. (BEST) stock gains during current market. Here’s the update?

Best Inc. (NASDAQ: BEST) stock rises by 5.45% during the current market. BEST Inc. is a prominent Chinese supplier of comprehensive smart supply chain...

Dolphin Entertainment Inc. (DLPN) stock rises during current market. Let’s find out why?

Dolphin Entertainment Inc. (NASDAQ: DLPN) stock gains by 17.47% to $9.21 today in the current market trading. Dolphin Entertainment is a leading independent entertainment...

General Electric Company Inc. (GE) stock sky-rocketing during pre-market. Here’s what you should know

General Electric Company Inc. (NASDAQ: GE) stock plunged by 2.56% at last close whereas the GE stock price surged massively during pre-market by 704.32%....

Related News

Best Inc. (BEST) stock gains during current market. Here’s the update?

Best Inc. (NASDAQ: BEST) stock rises by 5.45% during the current market. BEST Inc. is a prominent Chinese supplier of comprehensive smart supply chain...

Dolphin Entertainment Inc. (DLPN) stock rises during current market. Let’s find out why?

Dolphin Entertainment Inc. (NASDAQ: DLPN) stock gains by 17.47% to $9.21 today in the current market trading. Dolphin Entertainment is a leading independent entertainment...

CbdMD Inc. (YCBD) stock gains during after-market, given no recent update

CbdMD Inc. (NASDAQ: YCBD) stock soars by 5.43% in the after-hours trading session. CbdMD, Inc. is one of the most well-known and reputable cannabidiol...

UXIN stock declines during current market trading. What’s driving it low?

Uxin Ltd. (NASDAQ: UXIN) stock declines by 3.41% during current market trading. In China, Uxin Limited is a prominent online used vehicle dealer with...

Synthetic Biologics Inc. (SYN) stock plunged during pre-market. Here’s what you should know?

Synthetic Biologics Inc. (NASDAQ: SYN) stock gained by 8.09% at last close whereas the SYN stock price declines by 0.54% in the pre-market trading....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam